WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

FDA approves Moderna's new mRNA-based flu vaccine | The Jerusalem Post

The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.

Raccontata dabenzinga.comjpost.comhealio.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
jpost.comStai leggendo3 g fa

FDA approves Moderna's new mRNA-based flu vaccine | The Jerusalem Post

FDA approves Moderna's mFlusiva, an mRNA flu vaccine for 50+, with 27% greater efficacy than traditional shots. Faster manufacturing (2–3 months vs 6) enables real-time strain updates and positions mRNA as a platform for combination vaccines.

originale
healio.com1 g fa

FDA advisors back approval of mRNA flu shot

An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved for older adults.In two 9-0 votes, the…

Leggi questa versione → originale
benzinga.com5 g fa

Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR

Moderna's mRNA-1010 flu vaccine cleared FDA panel unanimously (9-0) for adults 50+; final approval expected Aug 5, 2026. This signals expansion from COVID-only into multi-respiratory franchise (flu, flu-COVID combo, norovirus), critical for offsetting concentrated revenue exposure.

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 19 giugno 2026·benzinga.com

    Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0 - Moderna (NASDAQ:MR

    Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.

  2. lunedì 22 giugno 2026·jpost.com

    FDA approves Moderna's new mRNA-based flu vaccine | The Jerusalem Post

    The vaccine, intended for people 50 and older, is based on mRNA technology and was found in an advanced trial to be more effective than a standard flu shot.

  3. mercoledì 24 giugno 2026·healio.com

    FDA advisors back approval of mRNA flu shot

    An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved…